Related Experiment Video

Updated: Aug 29, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Usefulness of anticoagulants in the prevention of ischemic stroke

Francisco Rubio1, Mario Jato

  • 1Neurology Department, Bellvitge University Hospital, Barcelona, Spain. frubio@csub.scs.es

Cerebrovascular Diseases (Basel, Switzerland)
|December 25, 2003
PubMed

Insights

Oral anticoagulants are vital for preventing embolic vascular diseases. However, their use in arterial conditions remains limited, with antiplatelet therapy often preferred for lower-risk heart and artery diseases.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Oral anticoagulants are established treatments for preventing embolic vascular events.
  • Current evidence suggests limited efficacy and satisfaction with anticoagulants in arterial disease management.

Purpose of the Study:

  • To evaluate the current role and limitations of oral anticoagulants in vascular disease prevention.
  • To compare the utility of anticoagulants versus antiplatelet agents in different cardiovascular conditions.

Main Methods:

  • Review of existing studies and clinical experience with oral anticoagulants.
  • Analysis of indications for anticoagulant therapy in embolic versus arterial processes.
  • Comparison with antiplatelet treatment strategies.

Main Results:

  • Oral anticoagulants are primarily indicated for heart diseases with significant embolic potential.
  • Experience with anticoagulants in arterial diseases has been unsatisfactory.
  • Antiplatelet therapy is a preferred alternative for low-risk heart diseases and arterial disease treatment.

Conclusions:

  • The primary indication for oral anticoagulants remains in high-embolic-risk cardiovascular conditions.
  • Antiplatelet agents are often more suitable for managing arterial diseases and lower-risk cardiac conditions.
  • Further research may be needed to explore novel applications or refine existing strategies for anticoagulation in specific vascular contexts.

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...